永安药业：控股股东、实际控制人之一致行动人拟减持不超过0.91%公司股份

Core Viewpoint - Yong'an Pharmaceutical (002365.SZ) announced that its controlling shareholder, Huanggang Yong'an Pharmaceutical Co., Ltd., plans to reduce its shareholding by up to 2.6323 million shares, accounting for 0.91% of the total share capital after excluding shares in the repurchase account, within three months from the fifteenth trading day after the announcement [1] Summary by Relevant Sections - Share Reduction Plan - The reduction will be executed through centralized bidding or block trading methods [1] - The reason for the reduction is operational needs, with shares sourced from those held prior to the initial public offering and from capital reserve conversion [1] - Impact on Control - This share reduction will not result in a change of control for the company [1]